Status:
COMPLETED
Olive Polyphenols in Cardiovascular Prevention
Lead Sponsor:
Nina Hermans
Collaborating Sponsors:
University Hospital, Antwerp
Conditions:
Hypertension, Systolic
Eligibility:
All Genders
18-76 years
Phase:
PHASE4
Brief Summary
The aim of this study is to evaluate whether the use of a commercially available standardized olive extract (Tensiofytol®) in individuals with elevated blood pressure 1. Leads to a clinically relevan...
Eligibility Criteria
Inclusion
- Systolic blood pressure ≥ 130 mmHg
Exclusion
- \<18 jaar
- \>76 jaar
- Smoking
- Use of nutritional supplements or (chronic) medication\*
- Triglycerides \> 400 mg/dL
- \> 14 alcoholic consumptions/week
- Chronic illness (e.g. diabetes, atherosclerosis, reumatoid arthritis)
- Acute infection
- Current pregnancy or pregnancy wish during the study period
- Breast feeding
- When nutritional supplements were used regularly, participation is allowed after a 10-day wash out period.
- Use of medication will be individually assessed and is permitted if it does not interfere with the used treatments and the patient is stable on the medication.
Key Trial Info
Start Date :
May 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 21 2024
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04874961
Start Date
May 20 2021
End Date
May 21 2024
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UAntwerp, NatuRAPT
Wilrijk, Belgium